Cross-cultural adaptation and validation of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) in Côte d'Ivoire (the Ivory Coast).


Journal

Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626

Informations de publication

Date de publication:
18 Mar 2020
Historique:
received: 28 12 2018
accepted: 12 03 2020
entrez: 20 3 2020
pubmed: 20 3 2020
medline: 25 8 2020
Statut: epublish

Résumé

Health-related quality of life evaluation is recognized as an important outcome in the assessment of boys with haemophilia. In fact, reliable health-related quality of life data are even more critical in developing countries to advocate for government agencies to develop national haemophilia care programmes. However, validated tools are not yet available in sub-Saharan African countries. The purpose of this study was to complete the cultural adaptation and validation of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool version The process included four steps: a linguistic adaptation, cognitive debriefing interviews with children and their parents, a validity assessment with the Pediatric Quality of Life Inventory (PedsQL) as a comparator, and a test-retest reliability assessment. The initial Ivoirian version of the CHO-KLAT A cross-culturally adapted and validated version of the CHO-KLAT

Identifiants

pubmed: 32188477
doi: 10.1186/s12955-020-01327-x
pii: 10.1186/s12955-020-01327-x
pmc: PMC7079424
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

76

Références

Haemophilia. 2017 Jul;23(4):497-510
pubmed: 28429867
Haemophilia. 2015 May;21(3):351-7
pubmed: 25471939
Eur J Haematol Suppl. 2014 Aug;76:2-15
pubmed: 24957102
Aust N Z J Public Health. 2016 Jun;40(3):294-5
pubmed: 27242256
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
Value Health. 2013 Jul-Aug;16(5):837-41
pubmed: 23947978
Haemophilia. 2016 Nov;22(6):894-897
pubmed: 27456858
Health Qual Life Outcomes. 2009 Oct 23;7:92
pubmed: 19852803
PLoS Negl Trop Dis. 2014 Dec 04;8(12):e3287
pubmed: 25474579
Ambul Pediatr. 2003 Nov-Dec;3(6):329-41
pubmed: 14616041
Haemophilia. 2012 May;18(3):353-7
pubmed: 22103664
Haemophilia. 2004 Mar;10 Suppl 1:34-43
pubmed: 14987247
Health Qual Life Outcomes. 2012 Sep 15;10:112
pubmed: 22978454
Haemophilia. 2006 Nov;12(6):643-53
pubmed: 17083516
N Engl J Med. 2001 Jun 7;344(23):1773-9
pubmed: 11396445
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
Haemophilia. 2014 Nov;20(6):794-9
pubmed: 25273150
Haemophilia. 2014 Jan;20(1):73-7
pubmed: 23919355
Pediatr Blood Cancer. 2006 Sep;47(3):305-11
pubmed: 16206209
Haemophilia. 2017 Sep;23(5):682-688
pubmed: 28440005
Qual Life Res. 2003 May;12(3):219-27
pubmed: 12769134
Haemophilia. 2013 Mar;19(2):e73-83
pubmed: 23167873
Haemophilia. 2006 Sep;12(5):518-25
pubmed: 16919083
Haemophilia. 2013 Nov;19(6):866-9
pubmed: 23786300
Thromb Haemost. 2001 Mar;85(3):560
pubmed: 11307831
Haemophilia. 2013 Nov;19(6):861-5
pubmed: 23786255

Auteurs

Catherine Lambert (C)

Haemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Brussels, Belgium. catherine.lambert@uclouvain.be.

N' Dogomo Meité (ND)

Division of Clinical Hematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Côte d'Ivoire.

Ibrahima Sanogo (I)

Division of Clinical Hematology, Centre Hospitalier Universitaire de Yopougon, Abidjan, Côte d'Ivoire.

Sébastien Lobet (S)

Haemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Division of Physical Medicine and Rehabilitation, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Université catholique de Louvain (UCLouvain), Secteur des Sciences de la Santé, Institut de Recherche Expérimentale et Clinique, Neuromusculoskeletal Lab, 1200, Brussels, Belgium.

Cedric Hermans (C)

Haemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Brussels, Belgium.

Séverine Henrard (S)

Clinical Pharmacy Research Group (CLIP), Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Institute of Health and Society (IRSS), Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Victor Blanchette (V)

Department of Pediatrics, University of Toronto, Toronto, ON, Canada.
Division of Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.

Nancy L Young (NL)

School of Rural and Northern Health, Laurentian University, Sudbury, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH